30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Boston Scientific Corp (BSX)

In the last 90 days, Boston Scientific Corp. saw net insider buying totaling $554,000 from 3 insiders. There were 4 buy transactions and no sell transactions. This activity occurred against a backdrop of a significant stock price decline of over 32% in the past 90 days.
Stock chart
Ticker: BSX Exchange: NYS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Pegus Cheryl
1 purchase — total 99,987 USD
Buy 20 May 2026
Value US$336,007.57 | Price 401.38 | Shares 79,994
Buy 20 May 2026
Value US$1,227,691.43 | Price 187.20 | Shares 78,167
Buy 20 May 2026
Value US$202,914.40 | Price 56.68 | Shares 3,580
Buy 19 May 2026
Value US$125,279.22 | Price 56.95 | Shares 2,200
Planned sale 2 Feb 2026
Value US$14,930,526.34 | Price 93.49 | Shares 159,701
Planned sale 2 Feb 2026
Value US$112,868.04 | Price 94.06 | Shares 1,200
Planned sale 2 Feb 2026
Value US$14,930,526.34 | Price 93.49 | Shares 159,701
Planned sale 2 Feb 2026
Value US$112,868.04 | Price 94.06 | Shares 1,200
Proposed sale 2 Feb 2026
Value US$15,043,390.17 | Price 93.49 | Shares 160,901
Planned sale 1 Dec 2025
Value US$1,758,188.82 | Price 101.55 | Shares 17,313
Proposed sale 1 Dec 2025
Value US$1,758,187.73 | Price 101.55 | Shares 17,313
Proposed sale 6 Nov 2025
Value US$284,171.33 | Price 97.96 | Shares 2,901
Planned sale 6 Nov 2025
Value US$1,266,977.75 | Price 98.28 | Shares 12,891
Planned sale 3 Nov 2025
Value US$2,921,895.34 | Price 99.14 | Shares 29,472
Planned sale 3 Nov 2025
Value US$1,688,749.13 | Price 99.76 | Shares 16,928
Planned sale 3 Nov 2025
Value US$362,693.16 | Price 100.75 | Shares 3,600
Proposed sale 3 Nov 2025
Value US$4,973,335.00 | Price 99.47 | Shares 50,000
Proposed sale 28 Oct 2025
Value US$296,591.81 | Price 102.24 | Shares 2,901
Planned sale 28 Oct 2025
Value US$296,598.82 | Price 102.24 | Shares 2,901
Planned sale 27 Oct 2025
Value US$1,010,300.69 | Price 101.13 | Shares 9,990
Proposed sale 27 Oct 2025
Value US$1,008,081.00 | Price 100.91 | Shares 9,990
Proposed sale 1 Oct 2025
Value US$4,923,325.00 | Price 98.47 | Shares 50,000
Planned sale 1 Oct 2025
Value US$4,107,844.37 | Price 98.38 | Shares 41,755
Planned sale 1 Oct 2025
Value US$815,482.44 | Price 98.91 | Shares 8,245
Planned sale 2 Sep 2025
Value US$2,981,755.06 | Price 105.85 | Shares 28,170
Planned sale 2 Sep 2025
Value US$2,289,661.38 | Price 104.89 | Shares 21,830
Proposed sale 2 Sep 2025
Value US$5,271,415.00 | Price 105.43 | Shares 50,000
Planned sale 1 Aug 2025
Value US$1,811,519.79 | Price 104.63 | Shares 17,313
Planned sale 1 Aug 2025
Value US$5,231,670.00 | Price 104.63 | Shares 50,000
Proposed sale 1 Aug 2025
Value US$1,811,518.85 | Price 104.63 | Shares 17,313
Proposed sale 1 Aug 2025
Value US$5,231,665.00 | Price 104.63 | Shares 50,000
Sale 29 Jul 2025
Value US$310,377.99 | Price 106.99 | Shares 2,901
Proposed sale 29 Jul 2025
Value US$310,377.99 | Price 106.99 | Shares 2,901
Sale 25 Jul 2025
Value US$424,120.40 | Price 106.03 | Shares 4,000
Proposed sale 25 Jul 2025
Value US$429,840.00 | Price 107.46 | Shares 4,000
Planned sale 1 Jul 2025
Value US$5,348,315.00 | Price 106.97 | Shares 50,000
Proposed sale 1 Jul 2025
Value US$5,348,310.00 | Price 106.97 | Shares 50,000
Proposed sale 4 Jun 2025
Value US$5,799,624.64 | Price 102.88 | Shares 56,372
Planned sale 4 Jun 2025
Value US$5,799,630.28 | Price 102.88 | Shares 56,372
Planned sale 2 Jun 2025
Value US$9,296,950.17 | Price 103.39 | Shares 89,921
Planned sale 2 Jun 2025
Value US$7,754,185.50 | Price 104.05 | Shares 74,522
Proposed sale 2 Jun 2025
Value US$17,051,132.37 | Price 103.69 | Shares 164,443
Sale 29 May 2025
Value US$418,367.60 | Price 104.59 | Shares 4,000
Proposed sale 29 May 2025
Value US$418,160.00 | Price 104.54 | Shares 4,000
Planned sale 21 May 2025
Value US$513,582.92 | Price 106.42 | Shares 4,826
Proposed sale 21 May 2025
Value US$513,582.92 | Price 106.42 | Shares 4,826
Planned sale 5 May 2025
Value US$477,956.88 | Price 104.54 | Shares 4,572
Proposed sale 5 May 2025
Value US$477,956.88 | Price 104.54 | Shares 4,572
Planned sale 1 May 2025
Value US$1,766,982.00 | Price 102.06 | Shares 17,314
Planned sale 1 May 2025
Value US$9,322,265.53 | Price 102.13 | Shares 91,282
Planned sale 1 May 2025
Value US$7,529,708.17 | Price 102.92 | Shares 73,161
Proposed sale 1 May 2025
Value US$16,851,966.37 | Price 102.48 | Shares 164,443
Proposed sale 1 May 2025
Value US$1,766,980.67 | Price 102.06 | Shares 17,314
Planned sale 21 Apr 2025
Value US$458,904.34 | Price 95.09 | Shares 4,826
Proposed sale 21 Apr 2025
Value US$458,904.34 | Price 95.09 | Shares 4,826
Planned sale 1 Apr 2025
Value US$16,445,071.54 | Price 100.01 | Shares 164,442
Proposed sale 1 Apr 2025
Value US$16,445,067.57 | Price 100.01 | Shares 164,442
Planned sale 21 Mar 2025
Value US$486,702.10 | Price 100.85 | Shares 4,826
Proposed sale 21 Mar 2025
Value US$486,702.10 | Price 100.85 | Shares 4,826
Planned sale 4 Mar 2025
Value US$50,431.66 | Price 104.63 | Shares 482
Planned sale 3 Mar 2025
Value US$750,464.85 | Price 104.97 | Shares 7,149
Planned sale 28 Feb 2025
Value US$999,872.31 | Price 101.13 | Shares 9,887
Proposed sale 25 Feb 2025
Value US$279,552.00 | Price 104.00 | Shares 2,688
Planned sale 25 Feb 2025
Value US$279,552.00 | Price 104.00 | Shares 2,688
Planned sale 24 Feb 2025
Value US$487,368.75 | Price 104.25 | Shares 4,675
Proposed sale 24 Feb 2025
Value US$1,416,087.64 | Price 104.23 | Shares 13,586
Planned sale 24 Feb 2025
Value US$1,416,133.99 | Price 104.23 | Shares 13,586
Proposed sale 24 Feb 2025
Value US$487,368.75 | Price 104.25 | Shares 4,675
Proposed sale 21 Feb 2025
Value US$504,992.64 | Price 104.64 | Shares 4,826
Planned sale 21 Feb 2025
Value US$504,992.64 | Price 104.64 | Shares 4,826
Proposed sale 19 Feb 2025
Value US$7,086,108.81 | Price 105.24 | Shares 67,333
Proposed sale 19 Feb 2025
Value US$159,078.50 | Price 105.35 | Shares 1,510
Proposed sale 19 Feb 2025
Value US$347,442.90 | Price 105.19 | Shares 3,303
Planned sale 19 Feb 2025
Value US$159,078.50 | Price 105.35 | Shares 1,510
Planned sale 19 Feb 2025
Value US$347,443.23 | Price 105.19 | Shares 3,303
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-21 2026-05-20 B Purchase Non-Executive Director
79,994 -49.7%
401.38
US$336,008
79,994 -49.7% 401.38 US$336,008
2026-05-21 2026-05-20 B Purchase Non-Executive Director
78,167 -2.8%
187.20
US$1,227,691
78,167 -2.8% 187.20 US$1,227,691
2026-05-21 2026-05-20 B Purchase Non-Executive Director
35,802 -2.6%
186.05
US$354,762
35,802 -2.6% 186.05 US$354,762
2026-05-21 2026-05-19 B Purchase Non-Executive Director
2,200 +23.3%
56.95
US$125,279
2,200 +23.3% 56.95 US$125,279
2026-02-03 2026-02-02 PlS Planned sale

Chairman, President & CEO

Executive Director
159,701 -10.2%
93.49
US$14,930,526
159,701 -10.2% 93.49 US$14,930,526
2026-02-03 2026-02-02 PlS Planned sale

Chairman, President & CEO

Executive Director
1,200 -0.1%
94.06
US$112,868
1,200 -0.1% 94.06 US$112,868
2026-02-03 2026-02-02 PlS Planned sale

Chairman, President & CEO

Executive Director
159,701 -10.2%
93.49
US$14,930,526
159,701 -10.2% 93.49 US$14,930,526
2026-02-03 2026-02-02 PlS Planned sale

Chairman, President & CEO

Executive Director
1,200 -0.1%
94.06
US$112,868
1,200 -0.1% 94.06 US$112,868
2026-02-02 2026-02-02 PrS Proposed sale

Officer; Director

Executive Director
160,901
93.49
US$15,043,390
160,901 93.49 US$15,043,390
2025-12-02 2025-12-01 PlS Planned sale

EVP& Grp Pres, MedSurg & APAC

Officer
17,313 -42.3%
101.55
US$1,758,189
17,313 -42.3% 101.55 US$1,758,189
2025-12-01 2025-12-01 PrS Proposed sale

Officer

Officer
17,313
101.55
US$1,758,188
17,313 101.55 US$1,758,188
2025-11-06 2025-11-06 PrS Proposed sale

Director

Non-Executive Director
2,901
97.96
US$284,171
2,901 97.96 US$284,171
2025-11-06 2025-11-06 PlS Planned sale Non-Executive Director
12,891 -34.8%
98.28
US$1,266,978
12,891 -34.8% 98.28 US$1,266,978
2025-11-04 2025-11-03 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
29,472 -14.2%
99.14
US$2,921,895
29,472 -14.2% 99.14 US$2,921,895
2025-11-04 2025-11-03 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
16,928 -7.5%
99.76
US$1,688,749
16,928 -7.5% 99.76 US$1,688,749
2025-11-04 2025-11-03 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
3,600 -1.6%
100.75
US$362,693
3,600 -1.6% 100.75 US$362,693
2025-11-03 2025-11-03 PrS Proposed sale

Officer

Officer
50,000
99.47
US$4,973,335
50,000 99.47 US$4,973,335
2025-10-28 2025-10-28 PrS Proposed sale

Director

Non-Executive Director
2,901
102.24
US$296,592
2,901 102.24 US$296,592
2025-10-28 2025-10-28 PlS Planned sale Non-Executive Director
2,901 -10.7%
102.24
US$296,599
2,901 -10.7% 102.24 US$296,599
2025-10-28 2025-10-27 PlS Planned sale Non-Executive Director
9,990 -27.0%
101.13
US$1,010,301
9,990 -27.0% 101.13 US$1,010,301
2025-10-27 2025-10-27 PrS Proposed sale

Director

Non-Executive Director
9,990
100.91
US$1,008,081
9,990 100.91 US$1,008,081
2025-10-01 2025-10-01 PrS Proposed sale

Officer

Officer
50,000
98.47
US$4,923,325
50,000 98.47 US$4,923,325
2025-10-01 2025-10-01 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
41,755 -19.0%
98.38
US$4,107,844
41,755 -19.0% 98.38 US$4,107,844
2025-10-01 2025-10-01 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
8,245 -3.6%
98.91
US$815,482
8,245 -3.6% 98.91 US$815,482
2025-09-03 2025-09-02 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
28,170 -13.6%
105.85
US$2,981,755
28,170 -13.6% 105.85 US$2,981,755
2025-09-03 2025-09-02 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
21,830 -9.6%
104.89
US$2,289,661
21,830 -9.6% 104.89 US$2,289,661
2025-09-02 2025-09-02 PrS Proposed sale

Officer

Officer
50,000
105.43
US$5,271,415
50,000 105.43 US$5,271,415
2025-08-04 2025-08-01 PlS Planned sale

EVP& Grp Pres, MedSurg & APAC

Officer
17,313 -42.3%
104.63
US$1,811,520
17,313 -42.3% 104.63 US$1,811,520
2025-08-04 2025-08-01 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
50,000 -21.9%
104.63
US$5,231,670
50,000 -21.9% 104.63 US$5,231,670
2025-08-01 2025-08-01 PrS Proposed sale

Officer

Officer
17,313
104.63
US$1,811,519
17,313 104.63 US$1,811,519
2025-08-01 2025-08-01 PrS Proposed sale

Officer

Officer
50,000
104.63
US$5,231,665
50,000 104.63 US$5,231,665
2025-07-30 2025-07-29 S Sale Non-Executive Director
2,901 -58.2%
106.99
US$310,378
2,901 -58.2% 106.99 US$310,378
2025-07-29 2025-07-29 PrS Proposed sale

Director

Non-Executive Director
2,901
106.99
US$310,378
2,901 106.99 US$310,378
2025-07-28 2025-07-25 S Sale Non-Executive Director
4,000 -17.8%
106.03
US$424,120
4,000 -17.8% 106.03 US$424,120
2025-07-25 2025-07-25 PrS Proposed sale

Director

Non-Executive Director
4,000
107.46
US$429,840
4,000 107.46 US$429,840
2025-07-02 2025-07-01 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
50,000 -21.9%
106.97
US$5,348,315
50,000 -21.9% 106.97 US$5,348,315
2025-07-01 2025-07-01 PrS Proposed sale

Officer

Officer
50,000
106.97
US$5,348,310
50,000 106.97 US$5,348,310
2025-06-04 2025-06-04 PrS Proposed sale

Officer

Officer
56,372
102.88
US$5,799,625
56,372 102.88 US$5,799,625
2025-06-04 2025-06-04 PlS Planned sale

EVP & Group Pres, Cardiology

Officer
56,372 -24.0%
102.88
US$5,799,630
56,372 -24.0% 102.88 US$5,799,630
2025-06-03 2025-06-02 PlS Planned sale

Chairman, President & CEO

Executive Director
89,921 -5.7%
103.39
US$9,296,950
89,921 -5.7% 103.39 US$9,296,950
2025-06-03 2025-06-02 PlS Planned sale

Chairman, President & CEO

Executive Director
74,522 -4.5%
104.05
US$7,754,186
74,522 -4.5% 104.05 US$7,754,186
2025-06-02 2025-06-02 PrS Proposed sale

Officer; Director

Executive Director
164,443
103.69
US$17,051,132
164,443 103.69 US$17,051,132
2025-05-30 2025-05-29 S Sale Non-Executive Director
4,000 -15.1%
104.59
US$418,368
4,000 -15.1% 104.59 US$418,368
2025-05-29 2025-05-29 PrS Proposed sale

Director

Non-Executive Director
4,000
104.54
US$418,160
4,000 104.54 US$418,160
2025-05-22 2025-05-21 PlS Planned sale

SVP, GC and Corp. Secretary

Officer
4,826 -13.3%
106.42
US$513,583
4,826 -13.3% 106.42 US$513,583
2025-05-21 2025-05-21 PrS Proposed sale

Officer

Officer
4,826
106.42
US$513,583
4,826 106.42 US$513,583
2025-05-06 2025-05-05 PlS Planned sale

EVP, Global Operations

Officer
4,572 -19.6%
104.54
US$477,957
4,572 -19.6% 104.54 US$477,957
2025-05-05 2025-05-05 PrS Proposed sale

Officer

Officer
4,572
104.54
US$477,957
4,572 104.54 US$477,957
2025-05-05 2025-05-01 PlS Planned sale

EVP& Grp Pres, MedSurg & APAC

Officer
17,314 -43.8%
102.06
US$1,766,982
17,314 -43.8% 102.06 US$1,766,982
2025-05-05 2025-05-01 PlS Planned sale

Chairman, President & CEO

Executive Director
91,282 -5.6%
102.13
US$9,322,266
91,282 -5.6% 102.13 US$9,322,266
2025-05-05 2025-05-01 PlS Planned sale

Chairman, President & CEO

Executive Director
73,161 -4.3%
102.92
US$7,529,708
73,161 -4.3% 102.92 US$7,529,708
2025-05-01 2025-05-01 PrS Proposed sale

Officer; Director

Executive Director
164,443
102.48
US$16,851,966
164,443 102.48 US$16,851,966
2025-05-01 2025-05-01 PrS Proposed sale

Officer

Officer
17,314
102.06
US$1,766,981
17,314 102.06 US$1,766,981
2025-04-22 2025-04-21 PlS Planned sale

SVP, GC and Corp. Secretary

Officer
4,826 -11.8%
95.09
US$458,904
4,826 -11.8% 95.09 US$458,904
2025-04-21 2025-04-21 PrS Proposed sale

Officer

Officer
4,826
95.09
US$458,904
4,826 95.09 US$458,904
2025-04-02 2025-04-01 PlS Planned sale

Chairman, President & CEO

Executive Director
164,442 -9.3%
100.01
US$16,445,072
164,442 -9.3% 100.01 US$16,445,072
2025-04-01 2025-04-01 PrS Proposed sale

Officer; Director

Executive Director
164,442
100.01
US$16,445,068
164,442 100.01 US$16,445,068
2025-03-24 2025-03-21 PlS Planned sale

SVP, GC and Corp. Secretary

Officer
4,826 -10.5%
100.85
US$486,702
4,826 -10.5% 100.85 US$486,702
2025-03-21 2025-03-21 PrS Proposed sale

Officer

Officer
4,826
100.85
US$486,702
4,826 100.85 US$486,702
2025-03-05 2025-03-04 PlS Planned sale

SVP, Global Controller and CAO

Officer
482 -52.7%
104.63
US$50,432
482 -52.7% 104.63 US$50,432
2025-03-05 2025-03-03 PlS Planned sale

SVP, Global Controller and CAO

Officer
7,149 -88.7%
104.97
US$750,465
7,149 -88.7% 104.97 US$750,465
2025-03-03 2025-02-28 PlS Planned sale

SVP, Global Controller and CAO

Officer
9,887 -85.8%
101.13
US$999,872
9,887 -85.8% 101.13 US$999,872
2025-02-25 2025-02-25 PrS Proposed sale

Officer

Officer
2,688
104.00
US$279,552
2,688 104.00 US$279,552
2025-02-25 2025-02-25 PlS Planned sale

EVP&Pres, Periph Intervent

Officer
2,688 -9.4%
104.00
US$279,552
2,688 -9.4% 104.00 US$279,552
2025-02-25 2025-02-24 PlS Planned sale

EVP&Pres, Periph Intervent

Officer
4,675 -14.1%
104.25
US$487,369
4,675 -14.1% 104.25 US$487,369
2025-02-24 2025-02-24 PrS Proposed sale

Director

Non-Executive Director
13,586
104.23
US$1,416,088
13,586 104.23 US$1,416,088
2025-02-24 2025-02-24 PrS Proposed sale

Officer

Officer
4,675
104.25
US$487,369
4,675 104.25 US$487,369
2025-02-24 2025-02-24 PlS Planned sale Non-Executive Director
13,586 -28.0%
104.23
US$1,416,134
13,586 -28.0% 104.23 US$1,416,134
2025-02-21 2025-02-21 PrS Proposed sale

Officer

Officer
4,826
104.64
US$504,993
4,826 104.64 US$504,993
2025-02-21 2025-02-21 PlS Planned sale

SVP, GC and Corp. Secretary

Officer
4,826 -9.5%
104.64
US$504,993
4,826 -9.5% 104.64 US$504,993
2025-02-19 2025-02-19 PrS Proposed sale

Officer

Officer
67,333
105.24
US$7,086,109
67,333 105.24 US$7,086,109
2025-02-19 2025-02-19 PrS Proposed sale

Officer

Officer
1,510
105.35
US$159,078
1,510 105.35 US$159,078
2025-02-19 2025-02-19 PrS Proposed sale

Officer

Officer
3,303
105.19
US$347,443
3,303 105.19 US$347,443
2025-02-19 2025-02-19 PlS Planned sale

EVP&Pres, Periph Intervent

Officer
1,510 -4.4%
105.35
US$159,078
1,510 -4.4% 105.35 US$159,078
2025-02-19 2025-02-19 PlS Planned sale

EVP, Global Operations

Officer
3,303 -13.6%
105.19
US$347,443
3,303 -13.6% 105.19 US$347,443